On this page
Beta-ketothiolase deficiency
This condition can lead to episodes of metabolic crisis, primarily affecting infants and young children. It requires careful management to prevent serious health complications.
Available at Jeen Health
Clinical tests that include this
Overview
Beta-ketothiolase deficiency is an inherited metabolic disorder where the body cannot properly break down certain branched-chain amino acids and fatty acids for energy. This happens because there is a problem with a specific enzyme called mitochondrial acetoacetyl-CoA thiolase, also known as beta-ketothiolase [PMID:19007471]. The condition is typically identified in infancy or early childhood, often during periods of illness or fasting.
Symptoms & clinical features
Symptoms of beta-ketothiolase deficiency can vary but often appear during metabolic crises. These crises can be triggered by infections, fasting, or increased protein intake. Typical symptoms include severe vomiting, lethargy, poor feeding, and a distinct sweet-smelling urine due to increased excretion of ketones. In more severe episodes, affected individuals may experience dehydration, difficulty breathing, seizures, and a reduced level of consciousness [PMID:16149179]. Without prompt treatment, these crises can lead to coma or be life-threatening.
Video: Genetics 101
Affected organs
While beta-ketothiolase deficiency is a systemic metabolic disorder, its effects are most acutely seen in the brain, which relies heavily on a consistent energy supply. During metabolic crises, the build-up of toxic substances and the lack of proper energy metabolism can impact brain function, leading to neurological symptoms like lethargy, seizures, and altered consciousness. Other organs, such as the liver and kidneys, may also be affected during severe episodes due to the widespread metabolic imbalance.
Risks & severity
The severity of beta-ketothiolase deficiency can vary, but individuals are at risk of recurrent metabolic crises, particularly in early childhood. These crises can lead to serious complications if not managed quickly, including intellectual disability, movement disorders, and in some cases, can be fatal [PMID:17410711]. With early diagnosis and careful management, the long-term outlook for individuals with beta-ketothiolase deficiency can be significantly improved, reducing the risk of severe developmental problems.
Genetic causes
Beta-ketothiolase deficiency is caused by pathogenic variants in the ACAT1 gene. This gene provides instructions for making an enzyme called mitochondrial acetoacetyl-CoA thiolase, which is also known as beta-ketothiolase [PMID:19007471]. This enzyme is critical for the fourth and final step in the breakdown of isoleucine (an amino acid) and for ketone body metabolism, which is a process the body uses to generate energy from fats. When the ACAT1 gene contains pathogenic variants, the enzyme is either absent or doesn't function correctly, leading to a build-up of harmful substances and an inability to produce energy effectively from these pathways.
- ACAT1 acetyl-CoA acetyltransferase 1The ACAT1 gene provides instructions for making an enzyme involved in critical metabolic processes, specifically breaking down proteins and fats to produce energy within cells.
Inheritance pattern
Beta-ketothiolase deficiency is inherited in an autosomal recessive pattern. This means that an individual must inherit two altered copies of the ACAT1 gene - one from each parent - to develop the condition. People who have only one altered copy of the gene are called carriers; they typically do not show symptoms of the condition themselves but can pass the altered gene on to their children. If both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two altered gene copies and develop beta-ketothiolase deficiency.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosis of beta-ketothiolase deficiency is often suspected based on clinical symptoms during a metabolic crisis, such as severe metabolic acidosis and ketosis. Initial biochemical tests on blood and urine can show elevated levels of specific organic acids like 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, and tiglylglycine [PMID:16149179]. Confirmation of the diagnosis typically involves genetic testing of the ACAT1 gene to identify pathogenic variants. This testing is usually coordinated through clinical genetics services, and in the UK, could be undertaken as part of an NHS Genomic Medicine Service pathway for rare metabolic conditions (e.g., using relevant R-codes).
Management & lifestyle
Management of beta-ketothiolase deficiency focuses on preventing metabolic crises and managing them promptly when they occur. This typically involves a special diet that restricts protein, particularly isoleucine, and may include fat modification. During illness or periods of fasting, a medical team will often advise increasing carbohydrate intake to provide an alternative energy source and prevent the body from breaking down fats and proteins. Close monitoring by a metabolic specialist and dietitian is essential. Regular follow-ups, emergency protocols for illness, and genetic counselling are standard parts of care within the NHS.
UK care pathway
In the UK, individuals suspected of having beta-ketothiolase deficiency would typically be referred to a consultant paediatrician or a metabolic diseases specialist. If a genetic cause is suspected, they would then be referred to a clinical genetics service. Genetic testing for rare metabolic conditions like beta-ketothiolase deficiency is accessible through the NHS Genomic Medicine Service (GMS), often utilising specific R-codes for inherited metabolic disorders. Genetic counsellors play a vital role in providing information and support to families regarding inheritance patterns and implications for other family members.
Frequently asked questions
What should I do if my child with beta-ketothiolase deficiency becomes unwell?
If your child has beta-ketothiolase deficiency and becomes unwell, especially with vomiting or reduced appetite, it's crucial to follow your metabolic team's emergency plan immediately. This often involves providing extra carbohydrates and seeking urgent medical attention.
Will my child need to be on a special diet forever?
Yes, individuals with beta-ketothiolase deficiency typically require a lifelong specialised diet that carefully manages protein and sometimes fat intake. This diet is supervised by a metabolic dietitian to ensure adequate nutrition while preventing metabolic crises.
Can beta-ketothiolase deficiency be detected before birth?
For families where beta-ketothiolase deficiency has been previously diagnosed, prenatal diagnosis is possible through genetic testing of the ACAT1 gene. This would typically be discussed with a genetic counsellor and can involve testing during pregnancy.
Is there a cure for beta-ketothiolase deficiency?
Currently, there is no cure for beta-ketothiolase deficiency. Management focuses on preventing serious complications through dietary control and strict adherence to emergency protocols during illness. Research is ongoing into new therapies for inherited metabolic disorders.
How common is beta-ketothiolase deficiency?
Beta-ketothiolase deficiency is considered a rare condition. The exact prevalence is not well established, but like many rare metabolic disorders, it affects a very small proportion of the population.
References
- Fukao T, Yamaguchi S, Orii T. Molecular basis of beta-ketothiolase deficiency: mutations and polymorphisms in the human mitochondrial acetoacetyl-coenzyme A thiolase gene. Human mutation. 1995. PMID: 7749408
- Kayani R, Botros S, Moore P. Beta-ketothiolase deficiency and pregnancy. International journal of obstetric anesthesia. 2013. PMID: 23664791
- Law CY, Lam CW, Ching CK. NMR-based urinalysis for beta-ketothiolase deficiency. Clinica chimica acta; international journal of clinical chemistry. 2015. PMID: 25195009
- Zhen XM, Twigg SM, Wu T. Diabetic ketoacidosis in an adult with beta-ketothiolase deficiency (BKD) involving a novel ACAT1 variant : first report of established diabetes in BKD and a review of the literature. Clinical diabetes and endocrinology. 2024. PMID: 38853254
- Orii T. Molecular basis of Zellweger syndrome, beta-ketothiolase deficiency and mucopolysaccharidoses. The Japanese journal of human genetics. 1997. PMID: 9183994
- Abdelkreem E, Akella RRD, Dave U. Clinical and Mutational Characterizations of Ten Indian Patients with Beta-Ketothiolase Deficiency. JIMD reports. 2017. PMID: 27928777
- Daley SF, Shah M. Newborn Screening. 2026. PMID: 32644409
- Grünert SC, Sass JO. 2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways. Orphanet journal of rare diseases. 2020. PMID: 32345314